Literature DB >> 11989544

Multi-organ renal failure in the elderly.

G H Neild1.   

Abstract

Periodically the question is posed "Why the persistently high mortality in acute renal failure?". By 1986, little progress seemed to have been made in improving outcome and it was stated that once oliguria was resistant to volume replacement and cardiac support, the patient had at best only a 50% chance of surviving. During the period 1960-1985, it can be shown that although outcome was not improving, older and sicker patients were being treated. Reviewing the literature of the past decade, the age and case mix of patients appears stable, but there is no suggestion of improvement in outcome. ARF with sepsis continues to have a mortality of 65 to 80%, and the outcome remains poor in elderly patients with failure of two or more organs. Progress has been slow in Intensive Care Units, and the past 20 years has seen little more than a move away from parenteral towards enteral feeding. Recent advances, however, in ventilatory techniques and the use of supra-physiological doses of glucocorticoids may lead to some improvement in outcome.

Entities:  

Mesh:

Year:  2001        PMID: 11989544     DOI: 10.1023/a:1014474305423

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  32 in total

1.  Intensive care for very elderly patients: outcome and risk factors for in-hospital mortality.

Authors:  N Van Den Noortgate; D Vogelaers; M Afschrift; F Colardyn
Journal:  Age Ageing       Date:  1999-05       Impact factor: 10.668

2.  The evolution of acute renal failure, 1956-1988.

Authors:  J H Turney; D H Marshall; A M Brownjohn; C M Ellis; F M Parsons
Journal:  Q J Med       Date:  1990-01

3.  Why is mortality persistently high in acute renal failure?

Authors:  J H Turney
Journal:  Lancet       Date:  1990-04-21       Impact factor: 79.321

4.  Total parenteral nutrition in the critically ill patient: a meta-analysis.

Authors:  D K Heyland; S MacDonald; L Keefe; J W Drover
Journal:  JAMA       Date:  1998-12-16       Impact factor: 56.272

5.  Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome.

Authors:  M B Amato; C S Barbas; D M Medeiros; R B Magaldi; G P Schettino; G Lorenzi-Filho; R A Kairalla; D Deheinzelin; C Munoz; R Oliveira; T Y Takagaki; C R Carvalho
Journal:  N Engl J Med       Date:  1998-02-05       Impact factor: 91.245

6.  Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Madrid Acute Renal Failure Study Group.

Authors:  F Liaño; J Pascual
Journal:  Kidney Int       Date:  1996-09       Impact factor: 10.612

7.  Why the persistently high mortality in acute renal failure.

Authors:  R B Stott; J S Cameron; C S Ogg; M Bewick
Journal:  Lancet       Date:  1972-07-08       Impact factor: 79.321

8.  Survivors of acute renal failure who do not recover renal function.

Authors:  S Bhandari; J H Turney
Journal:  QJM       Date:  1996-06

9.  Acute renal failure and outcome of continuous arteriovenous hemodialysis (CAVHD) and continuous hemofiltration (CAVH) in elderly patients following cardiovascular surgery.

Authors:  A Alarabi; S O Nyström; E Ståhle; B Wikström
Journal:  Geriatr Nephrol Urol       Date:  1997

10.  Prognosis of patients with acute renal failure in the intensive-care unit: a tale of two eras.

Authors:  J T McCarthy
Journal:  Mayo Clin Proc       Date:  1996-02       Impact factor: 7.616

View more
  8 in total

1.  Biomarker and drug-target discovery using proteomics in a new rat model of sepsis-induced acute renal failure.

Authors:  M K Holly; J W Dear; X Hu; A N Schechter; M T Gladwin; S M Hewitt; P S T Yuen; R A Star
Journal:  Kidney Int       Date:  2006-06-07       Impact factor: 10.612

2.  Chitinase-like proteins are candidate biomarkers for sepsis-induced acute kidney injury.

Authors:  B Maddens; B Ghesquière; R Vanholder; D Demon; J Vanmassenhove; K Gevaert; E Meyer
Journal:  Mol Cell Proteomics       Date:  2012-01-10       Impact factor: 5.911

Review 3.  Animal models of sepsis and sepsis-induced kidney injury.

Authors:  Kent Doi; Asada Leelahavanichkul; Peter S T Yuen; Robert A Star
Journal:  J Clin Invest       Date:  2009-10-01       Impact factor: 14.808

4.  Pathophysiological mechanisms underlying a rat model of triple whammy acute kidney injury.

Authors:  Laura Prieto-García; Laura Vicente-Vicente; Víctor Blanco-Gozalo; Omar Hidalgo-Thomas; María C García-Macías; Armin Kurtz; Anita T Layton; Ana B Sanz; Ana I Morales; Carlos Martínez-Salgado; Miguel Pericacho; Sandra M Sancho-Martínez; Francisco J López-Hernández
Journal:  Lab Invest       Date:  2020-07-27       Impact factor: 5.662

Review 5.  The aging kidney: increased susceptibility to nephrotoxicity.

Authors:  Xinhui Wang; Joseph V Bonventre; Alan R Parrish
Journal:  Int J Mol Sci       Date:  2014-09-01       Impact factor: 5.923

6.  Acute kidney injury and inflammatory response of sepsis following cecal ligation and puncture in d-galactose-induced aging rats.

Authors:  Chao Liu; Jie Hu; Zhi Mao; Hongjun Kang; Hui Liu; Wanlei Fu; Yangfan Lv; Feihu Zhou
Journal:  Clin Interv Aging       Date:  2017-03-29       Impact factor: 4.458

7.  Combined use of GM2AP and TCP1-eta urinary levels predicts recovery from intrinsic acute kidney injury.

Authors:  Víctor Blanco-Gozalo; Alfredo G Casanova; Sandra M Sancho-Martínez; Marta Prieto; Yaremi Quiros; Ana I Morales; Carlos Martínez-Salgado; Consuelo Agüeros-Blanco; Adalberto Benito-Hernández; María A Ramos-Barron; Carlos Gómez-Alamillo; Manuel Arias; Francisco J López-Hernández
Journal:  Sci Rep       Date:  2020-07-14       Impact factor: 4.379

Review 8.  Diagnosis of Cardiac Surgery-Associated Acute Kidney Injury: State of the Art and Perspectives.

Authors:  Alfredo G Casanova; Sandra M Sancho-Martínez; Laura Vicente-Vicente; Patricia Ruiz Bueno; Pablo Jorge-Monjas; Eduardo Tamayo; Ana I Morales; Francisco J López-Hernández
Journal:  J Clin Med       Date:  2022-08-05       Impact factor: 4.964

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.